Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Bioconjug Chem ; 29(5): 1748-1755, 2018 05 16.
Article in English | MEDLINE | ID: mdl-29648441

ABSTRACT

Peptide and protein drugs, which are categorized as biologics, exhibit poor membrane permeability. This pharmacokinetic disadvantage has largely restricted the development of noninvasive dosage forms of biologics that deliver into systemic circulation. We have been investigating the potential use of cell-penetrating peptide-linked polymers as a novel absorption enhancer to overcome this challenge. Since our previous study revealed that biocompatible poly( N-vinylacetamide- co-acrylic acid) modified with d-octaarginine, a typical cell-penetrating peptide, enhanced in vitro permeation of biomolecules such as plasmid DNA and bovine serum albumin through cell membranes, the present study evaluated whether the polymers enhanced in vivo absorption of biologics applied on the mucosa. Mouse experiments demonstrated that d-octaarginine-linked polymers drastically enhanced nasal absorption of exendin-4, whose injection is clinically used. The mean bioavailability was 20% relative to subcutaneous administration, even though it fell short of 1% when exendin-4 alone was administered nasally. The absorption-enhancing function of the polymers was superior to that of sodium caprate and sodium N-(8-(2-hydroxybenzoyl)amino) caprylate, which have been used for humans as an absorption enhancer. In vitro experiments using several biologics with different characteristics revealed that biologics interacted with d-octaarginine-linked polymers and were taken up into cells when incubated with the polymers. The interaction and cellular uptake were enhanced as molecular weights of the biologics increased; however, their charge-dependent in vitro performance was not clearly observed. The current data suggested that biologics formulated with our polymers became an alternative to their conventional invasive parenteral formulations.


Subject(s)
Exenatide/administration & dosage , Exenatide/pharmacokinetics , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/pharmacokinetics , Oligopeptides/metabolism , Pharmaceutical Vehicles/metabolism , Polymers/metabolism , Administration, Intranasal , Animals , Cell Line , Female , Mice , Mucous Membrane/metabolism , Oligopeptides/chemistry , Pharmaceutical Vehicles/chemistry , Polymers/chemistry
2.
Arch Toxicol ; 83(5): 477-83, 2009 May.
Article in English | MEDLINE | ID: mdl-19066852

ABSTRACT

Carbon tetrachloride (1 ml/kg body weight as a 1:1 mixture of CCl(4) and mineral oil) was orally administered to rats. After 12 h, the activity of plasma ALT (alanine aminotransferase) was significantly higher than that of the control group, and plasma ALT and AST (aspartate aminotransferase) activities significantly increased 24 h after CCl(4) administration. These results indicated that the necrotic process had initiated at about 12 h and developed thereafter. After 6-24 h of CCl(4) administration, the hepatic level of vitamin C, the most sensitive indicator of oxidative stress, decreased significantly, indicating that oxidative stress was significantly enhanced 6 h after CCl(4) intoxication and thereafter. Oral administration of vitamin E (1 ml/kg body weight as a 1:1 mixture of alpha-tocopherol and mineral oil) 12 h before CCl(4) administration caused a significant elevation of liver vitamin E level and ameliorated liver necrosis 24 h after CCl(4) intoxication based on plasma AST and ALT. Vitamin E also significantly restored the hepatic vitamin C concentration 12 and 24 h after CCl(4) intoxication, demonstrating that vitamin E functioned as an antioxidant. The liver vitamin E concentration was not changed by vitamin E supplementation to rats that did not receive CCl(4). This result indicated that vitamin E accumulated in the damaged liver. The activation of JNK, ERK1/2 and p38 MAPK took place 1.5 h after CCl(4) administration. Co-administration of alpha-tocopherol with CCl(4) did not affect these early changes in MAPKs.


Subject(s)
Carbon Tetrachloride Poisoning/metabolism , Liver/metabolism , alpha-Tocopherol/metabolism , Alanine Transaminase/blood , Animals , Ascorbic Acid/analysis , Ascorbic Acid/metabolism , Aspartate Aminotransferases/blood , Carbon Tetrachloride Poisoning/pathology , Liver/pathology , Male , Necrosis/chemically induced , Necrosis/metabolism , Rats , Rats, Wistar , Time Factors , Vitamin E/metabolism
3.
J Nutr Sci Vitaminol (Tokyo) ; 53(2): 160-5, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17616004

ABSTRACT

D-Galactosamine (D-Galn: 300 mg/kg) was intraperitoneally administered to rats. After 6 h the activity of plasma GOT and GPT was significantly higher than that of the control group and plasma GOT and GPT activities increased thereafter. These results indicated that the necrotic process was initiated at about 6 h and developed thereafter. With coadministration of DMSO (1 h before administration of D-Galn: 2.5 mL/kg, oral), plasma GOT and GPT were significantly lower, showing that DMSO inhibited the necrotic action of D-Galn. After 6-24 h of D-Galn administration, the hepatic level of vitamin C, the most sensitive indicator of oxidative stress, decreased significantly, indicating that oxidative stress was significantly enhanced 6 h after D-Galn intoxication and thereafter. DMSO significantly restored the liver vitamin C level 24 h after D-Galn injection, demonstrating that DMSO effectively ameliorated the oxidative stress caused by D-Galn, resulting in the prevention of necrosis of the liver. Phosphorylated JNK and phospho-ERK were significantly increased transiently 6-12 h after treatment with D-Galn. These results indicated that oxidative stress and the activation of JNK took place almost simultaneously. Phosphorylated p38 MAPK was not changed and DMSO treatment did not affect the change of these MAPKs by D-Galn.


Subject(s)
Dimethyl Sulfoxide/pharmacology , Free Radical Scavengers/pharmacology , Galactosamine/toxicity , Liver/pathology , Oxidative Stress/drug effects , Alanine Transaminase/blood , Alanine Transaminase/drug effects , Analysis of Variance , Animals , Ascorbic Acid/blood , Ascorbic Acid/metabolism , Aspartate Aminotransferases/blood , Aspartate Aminotransferases/drug effects , Blotting, Western/methods , Disease Models, Animal , Liver/drug effects , Male , Mitogen-Activated Protein Kinases/drug effects , Mitogen-Activated Protein Kinases/metabolism , Necrosis/chemically induced , Necrosis/prevention & control , Rats , Rats, Wistar , Time Factors
4.
J Nutr Sci Vitaminol (Tokyo) ; 53(1): 53-6, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17484380

ABSTRACT

In fulminant hepatic failure, various toxins causing multi-organ failure increase in plasma. As a novel toxin, levels of ceramide, a well-studied lipid mediator of apoptosis, were determined by LC-MS/MS in the liver and plasma of carbon tetrachloride (CCl4)-intoxicated rats. After 6 h of oral administration of CCl4 (4 mL/kg body weight as a 1:1 mixture of CCl4 and mineral oil) to rats, extensive hepatic failure occurred as evidenced by a severe elevation in plasma AST and ALT. The liver concentration of major ceramide components (C16:0, C24:0, C24:1, C18:0, C22:0, and C24:2 in decreasing order), and the sum of these ceramides increased significantly 2 h after CCl4 intoxication compared to that in the control group given mineral oil. The total ceramide concentration in the plasma was also increased to 4.1 times that in the control 24 h after administration of CCl4. In conclusion, the early increase in liver ceramides may contribute to hepatic cell death and the increase in plasma ceramides during fulminant hepatic failure may cause damage in other organs including the brain and kidney.


Subject(s)
Carbon Tetrachloride Poisoning/blood , Ceramides/blood , Liver/metabolism , Alanine Transaminase/blood , Alanine Transaminase/drug effects , Analysis of Variance , Animals , Aspartate Aminotransferases/blood , Aspartate Aminotransferases/drug effects , Biomarkers/blood , Carbon Tetrachloride Poisoning/complications , Cell Death/drug effects , Disease Models, Animal , Hepatocytes/drug effects , Hepatocytes/metabolism , Liver/drug effects , Liver Circulation/drug effects , Liver Failure, Acute/blood , Liver Failure, Acute/etiology , Male , Rats , Rats, Wistar , Time Factors
5.
Eur J Pharmacol ; 564(1-3): 190-5, 2007 Jun 14.
Article in English | MEDLINE | ID: mdl-17395177

ABSTRACT

Thioacetamide (400 mg/kg body weight, i.p.) was administered to rats. After 12 h the activity of plasma glutamate-oxaloacetate transaminase (GOT) and glutamate-pyruvate transaminase (GPT) was significantly higher than that of the control group, and after 24 h plasma GOT and GPT activities strongly increased. These results indicated that the necrotic process was initiated at about 12 h and developed thereafter. By co-administration of dimethyl sulphoxide (DMSO, 18 and 1 h before, and 8 h after administration of thioacetamide: each time, 2.5 ml/kg body weight, p.o.), plasma GOT and GPT were significantly decreased and were even comparable to the control group, showing that DMSO totally prevented the necrotic action of thioacetamide. After 12 and 24 h of thioacetamide administration, the hepatic level of vitamin C, the most sensitive chemical indicator of oxidative stress, decreased significantly, indicating that oxidative stress was significantly enhanced 12 h after thioacetamide intoxication and thereafter. DMSO totally restored the liver vitamin C level, demonstrating that DMSO effectively ameliorated the oxidative stress caused by thioacetamide, resulting in the prevention of necrosis of the liver. Phosphorylated c-Jun NH(2)-terminal kinase (JNK) significantly increased transiently 12 h after treatment with thioacetamide. These results indicated that oxidative stress and the activation of JNK took place almost simultaneously. Phosphorylated extracellular signal-related kinase (ERK) 2 was significantly increased 6-12 h after thioacetamide injection. Phosphorylated p38 MAPK (mitogen activated protein kinase) was significantly decreased 24 h after administration of thioacetamide. DMSO treatment inhibited the change of these MAPKs by thioacetamide, corresponding with the prevention of the liver necrosis as well as the attenuation of oxidative stress.


Subject(s)
Ascorbic Acid/metabolism , Dimethyl Sulfoxide/pharmacology , Free Radical Scavengers/pharmacology , Liver/drug effects , Animals , Aspartate Aminotransferases/blood , Aspartate Aminotransferases/drug effects , Blotting, Western , Extracellular Signal-Regulated MAP Kinases/drug effects , Extracellular Signal-Regulated MAP Kinases/metabolism , JNK Mitogen-Activated Protein Kinases/drug effects , JNK Mitogen-Activated Protein Kinases/metabolism , Liver/pathology , Liver/physiopathology , Male , Necrosis/chemically induced , Necrosis/prevention & control , Oxidative Stress/drug effects , Phosphorylation , Rats , Rats, Wistar , Thioacetamide/toxicity , Vitamin E/metabolism , p38 Mitogen-Activated Protein Kinases/drug effects , p38 Mitogen-Activated Protein Kinases/metabolism
6.
Arch Toxicol ; 81(7): 489-93, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17285312

ABSTRACT

Carbon tetrachloride (CCl(4): 4 ml/kg body weight as a 1:1 mixture of CCl(4) and mineral oil) was orally administered to rats. After 12 h the activity of plasma AST (aspartate aminotransferase) and ALT (alanine aminotransferase) was significantly higher than that of the control group and plasma AST and ALT activities increased thereafter. These results indicated that the necrotic process was active at about 12 h and developed thereafter. After 2-24 h of CCl(4) administration, the hepatic level of vitamin C, the most sensitive indicator of oxidative stress, decreased significantly, indicating that oxidative stress was significantly enhanced as early as 2 h after CCl(4) intoxication and thereafter. Phosphorylated JNK (c-Jun NH(2)-terminal kinase) and phospho-ERK1/2 (extracellular signal-regulated kinase1/2) were significantly increased transiently 1-3 h after treatment with CCl(4), while phosphorylated p38 decreased significantly 1-24 h after CCl(4) treatment. These results indicated that the change in MAPKs (mitogen activated protein kinases) slightly preceded that in vitamin C, the most sensitive chemical indicator of oxidative stress.


Subject(s)
Carbon Tetrachloride Poisoning/metabolism , Liver/metabolism , Mitogen-Activated Protein Kinases/metabolism , Oxidative Stress , Animals , Ascorbic Acid/metabolism , Carbon Tetrachloride Poisoning/enzymology , Carbon Tetrachloride Poisoning/pathology , Disease Models, Animal , Enzyme Activation , JNK Mitogen-Activated Protein Kinases/metabolism , Liver/enzymology , Liver/pathology , Male , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Necrosis , Phosphorylation , Rats , Rats, Wistar , Time Factors , p38 Mitogen-Activated Protein Kinases/metabolism
7.
Bioorg Med Chem Lett ; 16(11): 3019-22, 2006 Jun 01.
Article in English | MEDLINE | ID: mdl-16530410

ABSTRACT

A significant increase in plasma glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase was observed 6 h after intraperitoneal administration of D-galactosamine (D-Galn). Three hours after administration of D-Galn, the vitamin C concentration in the liver decreased significantly compared to that in a control group and thereafter the hepatic vitamin C concentration remained at a significantly lower level. Phosphorylated JNK (c-Jun NH2-terminal kinase) and phosphorylated ERK (extracellular signal-regulated kinase) started increasing 3 h after D-Galn treatment and remained at a high level for 6-12 h after the treatment, while phosphorylated p38 MAPK increased significantly 6 h after D-Galn administration. These results indicated that oxidative stress and the activation of JNK and ERK took place almost simultaneously, followed by the activation of p38 MAPK.


Subject(s)
Galactosamine/metabolism , Galactosamine/poisoning , Liver/drug effects , Liver/metabolism , Mitogen-Activated Protein Kinases/metabolism , Alkyl and Aryl Transferases/metabolism , Animals , Enzyme Activation/drug effects , Rats , Transferases (Other Substituted Phosphate Groups)/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL